Dr. Herbst on the 2011 Lung Cancer Congress Themes

Conference co-director, Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Comprehensive Cancer Center, describes the 12th International Lung Cancer Congress as very timely because it comes directly after the ASCO annual meeting and the World Lung Conference in Amsterdam.

Herbst describes the conference as a chance for practitioners to learn how the recent advances in the biology of lung cancer are translating into new therapies. One of the most unique aspects of the conference is that many of the presenters or representatives come from cooperative groups studying lung cancer from across the world. The conference provides a chance to become immersed in lung cancer therapy in order to understand recent advances and how they affect patients.